谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Impact of Lorlatinib on Patient-Reported Outcomes in Patients with Advanced ALK-positive or ROS1-positive Non-Small Cell Lung Cancer

Solange Peters,Alice T. Shaw,Benjamin Besse,Enriqueta Felip,Benjamin J. Solomon,Ross A. Soo,Alessandra Bearz,Shirish M. Gadgeel,Chia-Chi Lin,Steven Kao,Takashi Seto,Elizabeth T. Masters,Antonello Abbattista,Jill S. Clancy,Holger Thurm,Arlene Reisman,Gerson Peltz,D. Ross Camidge

Lung Cancer（2020）

引用 14|浏览150
暂无评分
关键词
ALK,Lorlatinib,NSCLC,Patient-reported outcomes,QoL,ROS1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要